PharmaStrategies > Compliance & Persistence
Compliance measures regularity in timing and dosage of intake.
Persistence measures continuity of following therapeutic recommendation over time.
Adherence measures the extent to which a patient's behavior agrees with recommendations from a health care provider.
The PharmaStrategies Programs significantly impacts these three dynamics. For Specialty Therapeutics we use the DiseaseTrak Therapy Management program and Specialty Pharmacies to ensure the highest quality of care for patients with severe chronic and life-altering diseases. All of the PharmaStrategies Programs address the elastic relationship between co-payments and adherence.
HealthCare Economist: "Increase copays and increase medical spending?"
http://healthcare-economist.com/2007/02/16/increase-copays-and-increase-medical-spending/
The American Journal of Managed Care: "Varying Pharmacy Benefits With Clinical Status: The Case of Cholesterol-lowering Therapy"
http://www.ajmc.com/Article.cfm?Menu=1&ID=3072
Pharmacy Times: "Low Generic Co-Pays Increase Compliance"
http://pharmacytimes.com/Article.cfm?Menu=1&ID=4285
National Bureau of Economic Research: "Effects of Co-payment on Prescription Drug Demand"
http://www.nber.org/digest/apr05/w10738.html
